http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4224509-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bb4eb230c4c655e344229422dc77bf6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate | 1992-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c49f8e61771210623b8ca92403e6b4d |
| publicationDate | 1994-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-4224509-A1 |
| titleOfInvention | Active ingredient for inhibiting the proliferation rate of liver cells |
| abstract | Agent for inhibiting proliferation of liver cells comprises the tripeptide SDK (Ser-Asp-Lys) or its salts. USE - Medicaments contg. the agent may be used to treat liver cancer, cirrhosis of the liver and chronic viral hepatitis. In an example, injection of rats with 1mcg SDK 10 hr. after partial (66%) hepatectomy reduced liver cell proliferation by ca. 50% compared with untreated controls. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9728183-A1 |
| priorityDate | 1992-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.